Gs/Gi
| Gsα
| All | + | | High affinity: C1a (amino terminus), C2a (α2, α3/β4) |
Yan et al., 1997a; Tesmer et al., 1997) |
| | | | | Low affinity: ACVI-C1b
|
Chen et al., 1997
|
| Gβγ
| I | − | CaM > Gsα >> forskolin | Unknown |
Tang and Gilman, 1991 |
| | II, IV, VII | + | Gsα >> forskolin | C2a (α3) |
Tang and Gilman, 1991; Gao and Gilman, 1991; Yoshimura et al., 1996; Chen et al. 1995 |
| Giα
| I, V, VI | − | | Unknown |
Taussig et al, 1994
|
| Goα
| I | − | CaM >> forskolin > Gsα
| Unknown |
Taussig et al., 1994
|
| Gzα
| I, V | − | | Unknown |
Kozasa and Gilman, 1995 |
Small chemicals | Forskolin | All except IX | + | Gsα synergy | C1/C2interface |
Zhang et al., 1997b; Tesmer et al.1997; Yan et al., 1998
|
| Adenosine | All | − | Enhanced by PPi | C1/C2 interface, cAMP competitor |
Tesmeret al. 1997; Liu et al., 1997 |
Feedback inhibition | PKA | V, VI | − | Gsα, forskolin | Ser674 (ACVI) |
Iwami et al., 1995; Chen et al., 1997
|
Ca2+/Gq
| Ca2+/CaM | I, VIII | + | | ACI-C1b (495–522), ACIII, VIII–unknown | Tang et al.; Cali et al., 1994;Vorherr et al., 1993; Wu et al., 1993
|
| PKC | II, V, VII | + | | ACII (1034-1068, Thr 1057) |
Kawabe et al., 1994; Jacobowitz and Iyengar, 1994;Yoshimura et al. 1993; Zimmermann and Taussig, 1996; Levin and Reed, 1995; Bol et al. 1997
|
| | VI | − | | Unknown |
Lai et al. 1997
|
| Ca2+
1-a
| V, VI | − | | C1b
1-b
|
Yoshimura and Cooper, 1992;Scholich et al. 1997 |
| CaM kinase1-a
| III | − | | |
Wei et al., 1996
|
| PP2B1-a
| IX | − | | |
Antoni et al., 1995
|